These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 11835311

  • 1. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S, Scherer SS, Nave KA, Suter U.
    J Neurosci Res; 2002 Feb 15; 67(4):443-9. PubMed ID: 11835311
    [Abstract] [Full Text] [Related]

  • 2. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
    Fortun J, Go JC, Li J, Amici SA, Dunn WA, Notterpek L.
    Neurobiol Dis; 2006 Apr 15; 22(1):153-64. PubMed ID: 16326107
    [Abstract] [Full Text] [Related]

  • 3. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A.
    Neurobiol Dis; 2004 Jun 15; 16(1):263-73. PubMed ID: 15207283
    [Abstract] [Full Text] [Related]

  • 4. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO, Gabreëls-Festen AA, Stoll G, Müller HW.
    Acta Neuropathol; 1997 Oct 15; 94(4):310-5. PubMed ID: 9341930
    [Abstract] [Full Text] [Related]

  • 5. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW.
    Neurobiol Dis; 2009 Mar 15; 33(3):448-58. PubMed ID: 19111616
    [Abstract] [Full Text] [Related]

  • 6. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
    Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D.
    Orphanet J Rare Dis; 2014 Dec 10; 9():201. PubMed ID: 25491744
    [Abstract] [Full Text] [Related]

  • 7. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury.
    Atanasoski S, Shumas S, Dickson C, Scherer SS, Suter U.
    Mol Cell Neurosci; 2001 Dec 10; 18(6):581-92. PubMed ID: 11749035
    [Abstract] [Full Text] [Related]

  • 8. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
    Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA.
    Ann N Y Acad Sci; 1999 Sep 14; 883():254-61. PubMed ID: 10586250
    [Abstract] [Full Text] [Related]

  • 9. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
    Hanemann CO, Gabreëls-Fasten AA, Müller HW, Stoll G.
    Brain; 1996 Oct 14; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
    [Abstract] [Full Text] [Related]

  • 10. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G, Visigalli D, Prukop T, Cervellini I, Mannino E, Venturi C, Bruzzone S, Sereda MW, Schenone A.
    Neurobiol Dis; 2016 Nov 14; 95():145-57. PubMed ID: 27431093
    [Abstract] [Full Text] [Related]

  • 11. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S, Young P, Suter U.
    Brain; 2001 Nov 14; 124(Pt 11):2177-87. PubMed ID: 11673320
    [Abstract] [Full Text] [Related]

  • 12. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R.
    Brain; 2015 Nov 14; 138(Pt 11):3193-205. PubMed ID: 26297559
    [Abstract] [Full Text] [Related]

  • 13. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW.
    Ann Neurol; 2007 Jan 14; 61(1):61-72. PubMed ID: 17262851
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA.
    Nat Med; 2003 Dec 14; 9(12):1533-7. PubMed ID: 14608378
    [Abstract] [Full Text] [Related]

  • 15. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
    Nobbio L, Fiorese F, Vigo T, Cilli M, Gherardi G, Grandis M, Melcangi RC, Mancardi G, Abbruzzese M, Schenone A.
    J Neuropathol Exp Neurol; 2009 May 14; 68(5):441-55. PubMed ID: 19525893
    [Abstract] [Full Text] [Related]

  • 16. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW.
    J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042
    [Abstract] [Full Text] [Related]

  • 17. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.
    Hantke J, Carty L, Wagstaff LJ, Turmaine M, Wilton DK, Quintes S, Koltzenburg M, Baas F, Mirsky R, Jessen KR.
    Brain; 2014 Nov 01; 137(Pt 11):2922-37. PubMed ID: 25216747
    [Abstract] [Full Text] [Related]

  • 18. A transgenic rat model of Charcot-Marie-Tooth disease.
    Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA.
    Neuron; 1996 May 01; 16(5):1049-60. PubMed ID: 8630243
    [Abstract] [Full Text] [Related]

  • 19. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M, Berger P, Nave KA, Suter U.
    Mol Cell Neurosci; 2002 May 01; 20(1):93-109. PubMed ID: 12056842
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory demyelination in a patient with CMT1A.
    Vital A, Vital C, Lagueny A, Ferrer X, Ribière-Bachelier C, Latour P, Petry KG.
    Muscle Nerve; 2003 Sep 01; 28(3):373-6. PubMed ID: 12929199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.